HOME
Lung Cancer Awareness Month
Month:
May 2016
Hepatitis C Therapy: Remaining Challenges and Solutions
Computer simulation of enzyme improves understanding of hepatitis C
Fas Ligand Based Immunotherapy: A Potent and Effective Neoadjuvant with Checkpoint Inhibitor Properties, or a Systemically Toxic Promoter of Tumor Growth?
CDC: Guidelines For Viral Hepatitis Surveillance And Case Management
Expensive Hep C Drugs Denied to Almost Half of Medicaid Patients
Hepatitis C linked to increased risk of liver cancer, other cancers
Burden of Hep C Virus Substantial Despite Oral Antiviral Therapy
May 19 is Hepatitis Testing Day!
Hepatitis C: elbasvir/grazoprevir combo tops popular treatment
CDC: Guidelines for Laboratory Testing of Hepatitis C
1
2
3
…
5
×